Livzon Pharmaceutical Gro... (LVZPF)

PNK: LVZPF · Real-Time Price · USD

3.43

0.00 (0.00%)

At close: May 01, 2025, 8:00 PM

Livzon Pharmaceutical Balance Sheet Statement

Financials in CNY. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
Cash & Equivalents	10.83B	11.33B	10.41B	9.15B	9.95B	8.86B	8.59B	7.42B	2.06B
Short-Term Investments	89.36M	81.79M	108.09M	182.77M	25.98M	17.19M	15.93M	8.73M	6.02M
Long-Term Investments	1.53B	1.67B	1.63B	1.51B	962.11M	634.04M	579.88M	277.4M	232.38M
Other Long-Term Assets	864.65M	233.65M	445.54M	757.3M	465.18M	411.87M	413.67M	359.59M	213.52M
Receivables	3.28B	3.57B	4.04B	3.29B	2.89B	2.43B	2.41B	2.51B	1.98B
Inventory	2B	2.06B	2.05B	1.66B	1.49B	1.17B	1.12B	1.1B	1.1B
Other Current Assets	72.68M	223.02M	383.32M	386.79M	267.74M	406.36M	339.78M	314.38M	826.29M
Total Current Assets	16.42B	17.27B	16.99B	14.67B	14.63B	12.87B	12.47B	11.35B	5.97B
Property-Plant & Equipment	4.54B	4.73B	4.59B	4.24B	3.71B	3.39B	3.4B	3.39B	3.54B
Goodwill & Intangibles	749.09M	839.08M	929.43M	937.82M	590.86M	481.1M	428.38M	392.17M	416.77M
Total Long-Term Assets	8.04B	7.78B	7.88B	7.7B	5.96B	5.1B	4.97B	4.55B	4.56B
Total Assets	24.46B	25.04B	24.86B	22.37B	20.59B	17.98B	17.44B	15.9B	10.53B
Account Payables	1.58B	1.66B	1.86B	1.82B	1.62B	1.27B	1.35B	501.67M	911.51M
Deferred Revenue	n/a	n/a	226.19M	3.04B	2.89B	2.52B	245.06M	3.13B	1.97B
Short-Term Debt	2.46B	1.86B	1.62B	2.05B	1.55B	1.36B	1.5B	400K	324.2M
Other Current Liabilities	192.11M	847.54M	3.56B	2.59B	119.25M	2.24B	116.46M	2.68B	104.89M
Total Current Liabilities	7.63B	8.09B	7.4B	6.93B	6.08B	5.29B	5.37B	4.41B	3.31B
Long-Term Debt	1.47B	1.61B	1.97B	636.78M	360.32M	n/a	700K	700K	700K
Other Long-Term Liabilities	2.00	90M	-185.9M	78M	497.42M	70M	n/a	n/a	1.00
Total Long-Term Liabilities	1.92B	2.19B	2.53B	1.14B	867.84M	407.57M	317.89M	253.08M	112.98M
Total Liabilities	9.55B	10.28B	9.93B	8.06B	6.95B	5.7B	5.69B	4.66B	3.42B
Total Debt	3.93B	3.48B	3.62B	2.69B	1.93B	1.36B	1.5B	1.1M	1.1M
Common Stock	911.35M	923.94M	935.55M	937.87M	944.84M	934.76M	719.05M	553.23M	425.73M
Retained Earnings	11.76B	10.91B	10.44B	9.72B	8.94B	8.42B	8.01B	8.03B	3.81B
Comprehensive Income	n/a	1.18B	1.14B	982.69M	1.02B	721.87M	611.63M	520.78M	501.78M
Shareholders Equity	13.86B	14.04B	13.88B	13B	12.11B	11.17B	10.65B	10.77B	6.51B
Total Investments	1.62B	1.76B	1.74B	1.69B	988.09M	651.24M	595.81M	286.13M	238.4M